Compounding, Beyond-Use Dating, and Equipment Records
A Flagstaff pharmacy compounds a preservative-free ophthalmic solution for a single patient and also prepares a batch of 30 prefilled syringes of a sterile drug for a local clinic. The pharmacy uses a dedicated room with a laminar airflow hood that has not been certified in 14 months. The refrigerator log shows a 6-hour gap in temperature readings last week, and the pharmacy's policy assigns beyond-use dating of 14 days at room temperature for the ophthalmic solution. The pharmacist preparing the batch has not completed a recent competency assessment for sterile compounding. The clinic wants the syringes delivered tomorrow.
1. Assess the hood certification and competency issues and their effect on the pharmacy's ability to release the batch.
Read the worked answer
Sterile compounding requires that the primary engineering control be certified initially and at least every 6 months, and that personnel who compound sterile preparations be trained and assessed for competency at defined intervals. A hood certified 14 months ago is out of compliance, and a pharmacist without a current competency assessment should not be preparing sterile preparations for patients.
The consequence is that the batch of 30 syringes cannot be released as sterile compounded preparations on this record. The pharmacy should not deliver them tomorrow. The correct sequence is: take the hood out of service until it is certified; arrange certification; remove the affected personnel from sterile compounding until competency is documented; and determine whether any product prepared during the uncertified period must be quarantined, recalled, or evaluated. The single-patient ophthalmic solution prepared in the same room is also affected if it was made while the hood was uncertified.
The pharmacist-in-charge should document the corrective actions, notify the clinic that delivery is delayed, and review whether the pharmacy should continue offering sterile compounding at all if it cannot maintain certification and training records.
2. The refrigerator log has a 6-hour gap. How should the pharmacist evaluate whether the affected products are still usable?
Read the worked answer
A temperature monitoring gap is a deviation that must be investigated, not ignored. The pharmacist should determine what was stored during the gap, obtain any available data (a secondary thermometer, a data logger, or a manual reading taken at the end of the gap), and assess whether the products were exposed to temperatures outside the labeled storage range.
If the temperature cannot be shown to have remained within range, the default is that the products are compromised for the period of uncertainty. The pharmacist should quarantine them, contact the manufacturer or the product's stability documentation for guidance, and document the disposition. For a compounded sterile preparation, the beyond-use date assumes proper storage; an unverified temperature excursion invalidates that assumption.
The pharmacy should also fix the root cause: assign a named person per shift to record temperatures, use a continuous monitoring device with alarms, and define what staff do when a reading is missed. The log gap itself is a recordkeeping deficiency even if no product was harmed.
3. Evaluate the 14-day room-temperature beyond-use date for the preservative-free ophthalmic solution and the recordkeeping the pharmacy must maintain.
Read the worked answer
The beyond-use date for a compounded sterile preparation must be supported by a stability basis appropriate to the preparation, the container, and the storage conditions. A preservative-free ophthalmic solution is a particularly sensitive case because it is both sterile and unpreserved, so microbial contamination risk drives a conservative dating. A blanket policy of 14 days at room temperature is not automatically valid; the pharmacist must be able to point to a documented basis - a stability study, published data, or the manufacturer's instructions for the source product - that supports the assigned date for that formulation and container.
If no basis exists, the pharmacist should assign a shorter, defensible date or prepare the solution as a single-patient, immediate-use preparation with the corresponding limits. The pharmacist should also confirm the container and closure are appropriate for ophthalmic use.
Records must include the master formulation record, the compounding record for each preparation, the components and lot numbers, the beyond-use date and the basis for it, the identity of the compounder and the pharmacist who verified the preparation, and the equipment certification and temperature logs. Without those records the pharmacy cannot demonstrate that the assigned dating was justified.